1.
Ibrahim N, Elzagheid A, El-Hashm H, Syrjänen K, Alhakim A. The Potential Value of EGFR and P53 Immunostaining in Tumors of the Urinary Bladder. LJM [Internet]. 2009 Nov. 27 [cited 2026 Oct. 12];4(4). Available from: https://www.ajol.info/index.php/ljm/article/view/48286